Selected article for: "recombinant protein and study recombinant protein"
Author: Liu, Xinsheng; Zhao, Donghong; Zhou, Peng; Zhang, Yongguang; Wang, Yonglu
Title: Evaluation of the Efficacy of a Recombinant Adenovirus Expressing the Spike Protein of Porcine Epidemic Diarrhea Virus in Pigs
  • Document date: 2019_10_8
    • ID: 1lxd2457_4
    Snippet: Currently, adenovirus vector systems derived from human adenoviruses have been widely used in the development of new-generation genetically engineered vaccines [25] [26] [27] . ey show more advantages than other vectors, such as easy construction, high efficiency for gene transfer and propagation, high titers and safety, and strong induction of humoral, mucosal, and cellular immune responses [25] . erefore, the recombinant adenovirus vector vacci.....
    Document: Currently, adenovirus vector systems derived from human adenoviruses have been widely used in the development of new-generation genetically engineered vaccines [25] [26] [27] . ey show more advantages than other vectors, such as easy construction, high efficiency for gene transfer and propagation, high titers and safety, and strong induction of humoral, mucosal, and cellular immune responses [25] . erefore, the recombinant adenovirus vector vaccine is a promising approach for the development of new viral vaccines. However, so far, toward a promising vaccine, the study of a recombinant adenovirus vector vaccine for PEDV is underdeveloped. erefore, the development of new PEDV vaccines based on recombinant adenovirus vectors is needed. To achieve this objective, in this study, a novel recombinant adenovirus expressing the PEDV S protein was generated, and its immunogenicity and protective efficacy were evaluated in 4-week-old pigs.

    Search related documents:
    Co phrase search for related documents
    • adenovirus vector and high efficiency: 1
    • adenovirus vector and high titer: 1, 2, 3, 4
    • adenovirus vector and human adenovirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • adenovirus vector and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • adenovirus vector vaccine and high titer: 1
    • adenovirus vector vaccine and human adenovirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • adenovirus vector vaccine and immune response: 1, 2, 3, 4, 5, 6
    • easy construction and gene transfer: 1
    • gene transfer and high efficiency: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • gene transfer and high titer: 1, 2
    • gene transfer and human adenovirus: 1, 2, 3, 4, 5, 6, 7
    • gene transfer and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • genetically engineer and immune response: 1
    • high efficiency and human adenovirus: 1, 2, 3
    • high efficiency and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • high efficiency and new generation: 1, 2, 3, 4
    • high efficiency and objective achieve: 1
    • high titer and human adenovirus: 1, 2, 3, 4, 5, 6, 7, 8
    • high titer and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25